أخبار السوق اليوم — عناوين الأسهم والعملات الرقمية المنتقاة بالذكاء الاصطناعي

The SEC and FDA have signed a three-year data-sharing agreement aimed at enhancing market oversight, though the article does not specify the sectors or assets directly targeted by this pact.

The SEC and FDA announced a Memorandum of Understanding (MOU) to enhance cooperation between the agencies in ensuring market integrity.

Cassidy takes aim at FDA mifepristone regulation, manufacturers OSV News

The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want …

HHS plans to name two deputy commissioners for technology and drugs, said two sources familiar with the matter.

MOUNTAIN VIEW, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life sciences …

Today, Aug. 19, 2026, Moderna's personalized cancer vaccine met its late-stage goal, with the company and Merck planning an FDA …

Aristotle Capital Management, LLC, an investment management company, released its “Core Equity Fund” Q2 2026 investor letter. A copy of …

Sweetgreen Inc. CEO Jonathan Neman says the cyclospora outbreak had an impact on the business but the US FDA now …

Steve Ostroff, Former Acting Commissioner of the FDA and Former Deputy Director of the National Center for Infectious Diseases at …

On this episode of Stock Movers: - RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from …

HHS moves to tighten oversight of food ingredients and define ultra-processed foods as food safety concerns raise questions about FDA …